160 related articles for article (PubMed ID: 31789316)
1. Preparation of Mitochondria from Ovarian Cancer Tissues and Control Ovarian Tissues for Quantitative Proteomics Analysis.
Zhan X; Li H; Qian S; Zhan X; Li N
J Vis Exp; 2019 Nov; (153):. PubMed ID: 31789316
[TBL] [Abstract][Full Text] [Related]
2. MASS SPECTROMETRY-BASED MITOCHONDRIAL PROTEOMICS IN HUMAN OVARIAN CANCERS.
Li N; Zhan X
Mass Spectrom Rev; 2020 Sep; 39(5-6):471-498. PubMed ID: 32020673
[TBL] [Abstract][Full Text] [Related]
3. The lncRNA SNHG3 regulates energy metabolism of ovarian cancer by an analysis of mitochondrial proteomes.
Li N; Zhan X; Zhan X
Gynecol Oncol; 2018 Aug; 150(2):343-354. PubMed ID: 29921511
[TBL] [Abstract][Full Text] [Related]
4. Quantitative proteome analysis of ovarian cancer tissues using a iTRAQ approach.
Wang LN; Tong SW; Hu HD; Ye F; Li SL; Ren H; Zhang DZ; Xiang R; Yang YX
J Cell Biochem; 2012 Dec; 113(12):3762-72. PubMed ID: 22807371
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of the mitochondrial proteome in human ovarian carcinomas.
Li N; Li H; Cao L; Zhan X
Endocr Relat Cancer; 2018 Oct; 25(10):909-931. PubMed ID: 29997262
[TBL] [Abstract][Full Text] [Related]
6. A straightforward and highly efficient precipitation/on-pellet digestion procedure coupled with a long gradient nano-LC separation and Orbitrap mass spectrometry for label-free expression profiling of the swine heart mitochondrial proteome.
Duan X; Young R; Straubinger RM; Page B; Cao J; Wang H; Yu H; Canty JM; Qu J
J Proteome Res; 2009 Jun; 8(6):2838-50. PubMed ID: 19290621
[TBL] [Abstract][Full Text] [Related]
7. Label-Free Quantitative Analysis of Mitochondrial Proteomes Using the Multienzyme Digestion-Filter Aided Sample Preparation (MED-FASP) and "Total Protein Approach".
Wiśniewski JR
Methods Mol Biol; 2017; 1567():69-77. PubMed ID: 28276014
[TBL] [Abstract][Full Text] [Related]
8. Quantitative profiling brain proteomes revealed mitochondrial dysfunction in Alzheimer's disease.
Adav SS; Park JE; Sze SK
Mol Brain; 2019 Jan; 12(1):8. PubMed ID: 30691479
[TBL] [Abstract][Full Text] [Related]
9. Altered mitochondrial proteome and functional dynamics in patients with rheumatoid arthritis.
Khanna S; Padhan P; Jaiswal KS; Jain AP; Ghosh A; Tripathy A; Gowda H; Raghav SK; Gupta B
Mitochondrion; 2020 Sep; 54():8-14. PubMed ID: 32544466
[TBL] [Abstract][Full Text] [Related]
10. The differentially mitochondrial proteomic dataset in human ovarian cancer relative to control tissues.
Zhan X; Zhou T; Li N; Li H
Data Brief; 2018 Oct; 20():459-462. PubMed ID: 30186894
[TBL] [Abstract][Full Text] [Related]
11. Increased WD-repeat containing protein 1 in interstitial fluid from ovarian carcinomas shown by comparative proteomic analysis of malignant and healthy gynecological tissue.
Haslene-Hox H; Oveland E; Woie K; Salvesen HB; Wiig H; Tenstad O
Biochim Biophys Acta; 2013 Nov; 1834(11):2347-59. PubMed ID: 23707566
[TBL] [Abstract][Full Text] [Related]
12. Quantitative proteomic analysis of mitochondria from human ovarian cancer cells and their paclitaxel-resistant sublines.
Chen M; Huang H; He H; Ying W; Liu X; Dai Z; Yin J; Mao N; Qian X; Pan L
Cancer Sci; 2015 Aug; 106(8):1075-83. PubMed ID: 26033570
[TBL] [Abstract][Full Text] [Related]
13. Large-Scale and Deep Quantitative Proteome Profiling Using Isobaric Labeling Coupled with Two-Dimensional LC-MS/MS.
Gritsenko MA; Xu Z; Liu T; Smith RD
Methods Mol Biol; 2016; 1410():237-47. PubMed ID: 26867748
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial proteomic analysis of cisplatin resistance in ovarian cancer.
Chappell NP; Teng PN; Hood BL; Wang G; Darcy KM; Hamilton CA; Maxwell GL; Conrads TP
J Proteome Res; 2012 Sep; 11(9):4605-14. PubMed ID: 22900918
[TBL] [Abstract][Full Text] [Related]
15. Comparative Proteomic Profiling Reveals Molecular Characteristics Associated with Oogenesis and Oocyte Maturation during Ovarian Development of Bactrocera dorsalis (Hendel).
Wei D; Li R; Zhang MY; Liu YW; Zhang Z; Smagghe G; Wang JJ
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28665301
[TBL] [Abstract][Full Text] [Related]
16. Quantitative proteomics revealed energy metabolism pathway alterations in human epithelial ovarian carcinoma and their regulation by the antiparasite drug ivermectin: data interpretation in the context of 3P medicine.
Li N; Li H; Wang Y; Cao L; Zhan X
EPMA J; 2020 Dec; 11(4):661-694. PubMed ID: 33240452
[TBL] [Abstract][Full Text] [Related]
17. Understanding Ovarian Cancer: iTRAQ-Based Proteomics for Biomarker Discovery.
Swiatly A; Horala A; Matysiak J; Hajduk J; Nowak-Markwitz E; Kokot ZJ
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30065196
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial comparative proteomics of human ovarian cancer cells and their platinum-resistant sublines.
Dai Z; Yin J; He H; Li W; Hou C; Qian X; Mao N; Pan L
Proteomics; 2010 Nov; 10(21):3789-99. PubMed ID: 20957754
[TBL] [Abstract][Full Text] [Related]
19. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
[TBL] [Abstract][Full Text] [Related]
20. In-depth LC-MS/MS analysis of the chicken ovarian cancer proteome reveals conserved and novel differentially regulated proteins in humans.
Nepomuceno AI; Shao H; Jing K; Ma Y; Petitte JN; Idowu MO; Muddiman DC; Fang X; Hawkridge AM
Anal Bioanal Chem; 2015 Sep; 407(22):6851-63. PubMed ID: 26159569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
